Meeting Overview - The first H-share class shareholders' meeting of Rongchang Biopharmaceuticals was held on June 26, 2025, in Yantai, Shandong Province [1] - A total of 111 ordinary shareholders attended the meeting, with 108 being A-share shareholders and 3 being H-share shareholders [1] Voting Results - The voting results showed that the majority of the proposals were approved, with ordinary shareholders voting 99.9689% in favor of the proposals [1][2] - A-share shareholders voted 99.9848% in favor, while H-share shareholders' voting results were not detailed in the provided data [1][2] Legal Compliance - The meeting was conducted in accordance with the Company Law and the company's articles of association, ensuring that the procedures and voting methods were legally valid [1][7] - The lawyers present confirmed that the meeting's procedures and results were compliant with relevant laws and regulations [7]
荣昌生物: 荣昌生物2024年年度股东大会、2025年第一次A股类别股东大会及2025年第一次H股类别股东大会决议公告